Impacto de la infección por COVID-19 en pacientes con enfermedades reumáticas autoinmunes

Abstract

Objective: To describe the impact of COVID-19 infection in patients with autoimmune rheumatic diseases. Methodology: A descriptive non-experimental study of bibliographic review type was carried out, therefore, research articles indexed and published in the last 3 years, in Spanish and English language in databases such as PubMed, Web of Science were used. Keywords such as rheumatologic agent, autoimmune diseases, covid-19, rheumatic disease were used for the consultation in the different search engines. Results: COVID-19 infection in patients with autoimmune rheumatic diseases is no different than in the general population, and it has even been shown that there is a lower risk of infection and severe infectious disease due to the use of drugs that reduce the systemic response. Likewise, the presence of comorbidities, corticosteroids or rituximab consumption influence the clinical evolution. Conclusions: The impact of COVID-19 infection on people diagnosed with autoimmune rheumatic disease are just as likely to be infected as the general population. It has even been shown that there is a reduced risk of infection and serious infectious disease due to the use of drugs that reduce the systemic response. The main symptoms found were fever, cough, chills, and dyspnea.